Nanogen, Inc. (NGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nanogen, Inc. (NGEN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sam Nizam who started this subject	4/17/2002 3:02:51 PM
From: nigel bates	Read Replies (1) of 258

NEW YORK, April 17 - Australian genomics company Genetic Technologies Group has given Nanogen a non-exclusive license to some of its gene patents. Terms of the deal call for Nanogen to fork over about $620,000 in cash and securities in exchange for a number of patents GTG holds for certain non-coding, or junk, regions of human genes, GTG said yesterday. The deal comes on the heels of a similar agreement with Sequenom worth roughly $537,000 signed last week. GTG, a publicly traded company, is based in Melbourne.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next